Funding Information for HIV/Hepatitis/STD/TB 10/13/2016

Having trouble viewing this email? View it as a Web page.

 

Thursday, October 13, 2016 The following funding information has been recently added to the CDC National Prevention Information Network's (NPIN) Funding Database (http://npin.cdc.gov/search/funding).

Fund Number: 5212 - Fund Title: HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control (UG3/UH3)

Fund Number: 5212 Fund Title: HIV, HCV and Related Comorbidities in Rural Communities Affected by Opioid Injection Drug Epidemics in the United States: Building Systems for Prevention, Treatment and Control (UG3/UH3) Fund Category: HIV/AIDS Description: This FOA will support biphasic (i.e., two stage, multi-method) research projects that inform community response and promote comprehensive, integrated approaches to prevent HIV and hepatitis C virus (HCV) infection, along with associated comorbidities such as hepatitis B virus (HBV) infection and sexually transmitted diseases (STDs), among people who inject drugs (PWID) in rural US communities. Opioid injection and its consequences (e.g., HIV, HCV, HBV, STDs and overdose) are the primary foci here. These projects should yield evidence of the effectiveness of community response models and best practices in responding to opioid injection epidemics that can be implemented by public health systems in similar rural communities in the US. Sponsor(s): US Department of Health and Human Services National Institutes of Health      -- AND -- US Department of Health and Human Services Public Health Service Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention      -- AND -- National Center for US Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention Funder's Fund ID: RFA-DA-17-014 Web Page: grants.nih.gov/grants/guide/rfa-files/RFA-DA-17-014.html Letter of Intent Date: 12/10/2017 Application Due Date: 01/10/2017 Fund Duration: The maximum project period is 5 years: up to 2 years for the first phase (UG3) and up to 3 years for the second phase (UH3). Application Process: It is critical that applicants follow the instructions in the Research Instructions for the SF424 (R&R) Application Guide, including Supplemental Grant Application Instructions except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review. Number of Awards: Varies Total Award: $6,500,000.00 Award Notes: NIDA and partner components and agencies intend to commit an estimated total of $6.5 Million in FY2017 to fund 8-10 UG3 awards. Future year amounts will depend on annual appropriations and successful completion of UG3 study benchmarks that permit continuation to the UH3 award. It is anticipated that 6-8 UH3 awards will be funded. Eligible Locations: - National Fund Notes: RFA-DA-17-023, U24 Resource-Related Research Projects--Cooperative Agreements Application Contact Name: Richard Jenkins PhD Application Contact Address: United States Email: jenkinsri@mail.nih.gov Phone: 301-443-1923 Technical Contact Name: Title: GrantsInfo Technical Contact Address: United States Email: GrantsInfo@nih.gov Phone: 301-710-0267 Contact Note: For additional agency contacts, please see complete FOA. Support Types: - Cooperative Agreements Subject Areas: - Drug Abuse - Hepatitis - HIV - Sexually Transmitted Diseases (STDs) Audiences: - Researchers Eligibility: - Colleges/Universities - County Agencies - Federal Government Agencies - IRS 501 (c)(3) Organizations - Minority Owned Organizations - Nonprofit Organizations - Religious Organizations - Research Institutions - State Agencies - Tribal Organizations - Woman Owned Organizations Eligibility Notes: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs); U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Back to Top

NPIN provides the Funding Announcements Update electronic mailing list as a public service only. Listings come from federal government agencies and private organizations that fund HIV/AIDS, viral hepatitis, STD, and TB prevention work. Inclusion does not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. For more information on a specific funding opportunity, please contact the funder. If you have information about your organization's funding opportunities that you would like included in the NPIN databases and/or in the e-mail announcements, please send it via e-mail to npin-info@cdc.gov. **This message may be copied and distributed; however, it may not be distributed for profit.**

---

Questions? Contact Us

STAY CONNECTED:

SUBSCRIBER SERVICES:
Manage Preferences  |  Unsubscribe  |  Help

Tweet

Postingan terkait:

— Thursday, October 13, 2016 — Add Comment